SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001284
Filing Date
2024-08-12
Accepted
2024-08-12 06:50:46
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lptx-20240630x10q.htm   iXBRL 10-Q 1615718
2 EX-10.2 lptx-20240630xex10d2.htm EX-10.2 266355
3 EX-31.1 lptx-20240630xex31d1.htm EX-31.1 10917
4 EX-32.1 lptx-20240630xex32d1.htm EX-32.1 6891
  Complete submission text file 0001410578-24-001284.txt   6688956

Data Files

Seq Description Document Type Size
5 EX-101.SCH lptx-20240630.xsd EX-101.SCH 47624
6 EX-101.CAL lptx-20240630_cal.xml EX-101.CAL 38482
7 EX-101.DEF lptx-20240630_def.xml EX-101.DEF 172632
8 EX-101.LAB lptx-20240630_lab.xml EX-101.LAB 428602
9 EX-101.PRE lptx-20240630_pre.xml EX-101.PRE 305258
65 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20240630x10q_htm.xml XML 981131
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 241194686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)